Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Business Wire
Dexcom G6 is the first Continuous Glucose Monitoring (CGM) System to be listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to announce the Dexcom G6 CGM System is now covered by the Non-Insured Health Benefits (NIHB) Program for people living with diabetes who are between 2 and 19 years old and require intensive insulin therapy. This expanded coverage will give more First Nations and Inuit children and adolescents access to this standard of care, potentially helping them to have more control over a life-long chronic illness.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210913005728/en/NIHB clients ages 2 to 19 on intensive insulin therapy are now eligible for coverage of the Dexcom G6 CGM System. (Photo: Business Wire)“Indigenous, First Nations and Inuit communities are disproportionately
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year [Yahoo! Finance]Yahoo! Finance
- Electronic Skin Patch Market worth $27.0 billion by 2029 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Market Analysis Forecasts Substantial Growth for Global Artificial Pancreas Device Systems - Projections to 2032 - Technological Innovations and Regulatory Support [Yahoo! Finance]Yahoo! Finance
- Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/2/24 - Form 4
- 4/30/24 - Form 144
- 4/25/24 - Form 10-Q
- DXCM's page on the SEC website